We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
How to use an interrupted time series to evaluate your digital health product.
Using an ecological momentary assessment to evaluate your digital health product.
How to use an N-of-1 study to evaluate your digital health product.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
How to use a crossover randomised controlled trial to evaluate your digital health product.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
Guidance for commissioners and health professionals to make decisions about mental health services and interventions based on data and analysis.
The commons listed on this page now have more eligible area to allocate for certain years of the Single Payment Scheme (SPS), Hill Farm Allowance (HFA) 2010 or Uplands Transitional Payment (UTP).
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to prepare and analyse the data you collected for your evaluation.
Information for companies on the import and export of controlled drugs to and from the UK.
How to use a quasi-experimental study to evaluate your digital health product.
How to use a randomised controlled trial to evaluate your digital health product.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Standardisation explained.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).